Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
La Verde N, Damia G, Garrone O, Santini D, Fabi A, Ciccarese M, Generali DG, Nunzi M, Poletto E, Ferraris E, Cretella E, Scandurra G, Meattini I, Bertolini AS, Cavanna L, Collovà E, Romagnoli E, Rulli E, Legramandi L, Guffanti F, Bramati A, Moretti A, Cassano A, Vici P, Torri V, Farina G; PAINTER investigators. La Verde N, et al. Among authors: fabi a. Breast Cancer Res. 2022 Oct 28;24(1):71. doi: 10.1186/s13058-022-01560-w. Breast Cancer Res. 2022. PMID: 36307826 Free PMC article. Clinical Trial.
Weekly epirubicin plus lonidamine in advanced breast carcinoma.
Nisticò C, Garufi C, Milella M, D'Ottavio AM, Vaccaro A, Fabi A, Terzoli E. Nisticò C, et al. Among authors: fabi a. Breast Cancer Res Treat. 1999 Aug;56(3):233-7. doi: 10.1023/a:1006213815195. Breast Cancer Res Treat. 1999. PMID: 10573114 Clinical Trial.
Weekly schedule of vinorelbine in pretreated breast cancer patients.
Nisticò C, Garufi C, Milella M, Vaccaro A, D'Ottavio AM, Fabi A, Pace A, Bove L, Tropea F, Marsella A, Izzo F, D'Attino RM, Ferraresi V, De Marco S, Terzoli E. Nisticò C, et al. Among authors: fabi a. Breast Cancer Res Treat. 2000 Feb;59(3):223-9. doi: 10.1023/a:1006390700480. Breast Cancer Res Treat. 2000. PMID: 10832592 Clinical Trial.
Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.
Ceribelli A, Gridelli C, De Marinis F, Fabi A, Gamucci T, Cortesi E, Barduagni M, Antimi M, Maione P, Migliorino MR, Giannarelli D, Cognetti F. Ceribelli A, et al. Among authors: fabi a. Cancer. 2003 Jul 15;98(2):337-43. doi: 10.1002/cncr.11501. Cancer. 2003. PMID: 12872354 Free article. Clinical Trial.
Alfa-epoietin and anaemia in gynaecological cancer.
Di Cocco B, Salesi N, Fabi A, Nardoni C, Ferretti G, Bossone G, Ciccarese M, Savarese A, Vecchione A, Cognetti F. Di Cocco B, et al. Among authors: fabi a. Anticancer Res. 2004 Mar-Apr;24(2C):1287-92. Anticancer Res. 2004. PMID: 15154662 Free article. Review.
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.
Di Cosimo S, Alimonti A, Ferretti G, Sperduti I, Carlini P, Papaldo P, Fabi A, Gelibter A, Ciccarese M, Giannarelli D, Mandalà M, Milella M, Ruggeri EM, Cognetti F. Di Cosimo S, et al. Among authors: fabi a. Ann Oncol. 2004 Jul;15(7):1065-71. doi: 10.1093/annonc/mdh266. Ann Oncol. 2004. PMID: 15205200 Free article.
326 results